HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidenori Shiraha Selected Research

Transcription Factor 3

5/2016Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.
8/2013Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer.
4/2013Human hepatocyte carcinogenesis (review).
12/2012Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
9/2011Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
3/2011Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma.
1/2011Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidenori Shiraha Research Topics

Disease

44Hepatocellular Carcinoma (Hepatoma)
04/2021 - 01/2005
39Neoplasms (Cancer)
04/2022 - 02/2009
7Neoplasm Metastasis (Metastasis)
04/2022 - 01/2007
6Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2011
6Liver Cirrhosis (Hepatic Cirrhosis)
05/2021 - 12/2012
5Infections
02/2019 - 11/2010
5Disease Progression
01/2017 - 07/2006
5Pancreatic Neoplasms (Pancreatic Cancer)
07/2016 - 08/2013
5Liver Diseases (Liver Disease)
09/2015 - 01/2008
5Hepatitis
07/2015 - 07/2006
4Fibrosis (Cirrhosis)
05/2021 - 01/2014
4Non-alcoholic Fatty Liver Disease
05/2021 - 09/2012
3Ascites
05/2021 - 07/2011
3Hepatitis B
02/2019 - 12/2011
3Cholangiocarcinoma
07/2016 - 03/2015
3Liver Neoplasms (Liver Cancer)
09/2015 - 01/2010
3Chronic Hepatitis (Chronic Active Hepatitis)
09/2015 - 11/2010
2Liver Failure
02/2022 - 12/2012
2Hyponatremia
05/2021 - 12/2020
2Acute Liver Failure (Fulminant Hepatic Failure)
02/2019 - 01/2011
2Pain (Aches)
01/2019 - 12/2014
2Hepatitis C
07/2015 - 07/2004
2Inflammation (Inflammations)
03/2015 - 09/2012
2Alcoholic Fatty Liver
03/2015 - 01/2014
2Sclerosing Cholangitis
01/2014 - 09/2012
2Thrombosis (Thrombus)
08/2013 - 07/2011
2Colorectal Neoplasms (Colorectal Cancer)
11/2007 - 03/2007
1Focal Nodular Hyperplasia
02/2022
1Rupture
02/2022
1Gallbladder Neoplasms (Gallbladder Cancer)
10/2021
1Hyperaldosteronism (Conn Syndrome)
05/2021
1Edema (Dropsy)
12/2020
1Dehydration (Water Stress)
12/2020
1Pathologic Constriction (Stenosis)
12/2020
1Weight Loss (Weight Reduction)
12/2020
1Vomiting
08/2019
1Fever (Fevers)
08/2019
1End Stage Liver Disease
02/2019
1Chronic Hepatitis B
01/2019
1Hypophosphatemia
01/2019
1Bone Fractures (Bone Fracture)
01/2019
1Osteomalacia
01/2019

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
04/2022 - 01/2011
8Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2011
8acarboxyprothrombin (PIVKA)IBA
04/2021 - 02/2005
7Transcription Factor 3IBA
05/2016 - 01/2011
6Polysaccharides (Glycans)IBA
09/2015 - 01/2013
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
05/2021 - 02/2011
4Prothrombin (Factor II)IBA
07/2020 - 02/2005
4Sorafenib (BAY 43-9006)FDA Link
06/2019 - 11/2011
4Immunoglobulins (Immunoglobulin)IBA
02/2019 - 12/2011
4Fluorouracil (Carac)FDA LinkGeneric
05/2016 - 11/2006
4InterferonsIBA
01/2014 - 07/2004
4DNA (Deoxyribonucleic Acid)IBA
12/2011 - 07/2006
3AntioxidantsIBA
08/2020 - 01/2014
3CytokinesIBA
06/2019 - 01/2014
3Cisplatin (Platino)FDA LinkGeneric
10/2018 - 05/2016
2Laminin (Merosin)IBA
04/2022 - 06/2021
2Serum AlbuminIBA
02/2022 - 06/2011
2TolvaptanFDA Link
05/2021 - 12/2020
2SodiumIBA
05/2021 - 12/2020
2Telomerase (Telomerase Reverse Transcriptase)IBA
04/2021 - 01/2020
2Therapeutic UsesIBA
01/2020 - 10/2017
2SteroidsIBA
08/2019 - 01/2013
2hepatitis B hyperimmune globulinIBA
02/2019 - 12/2011
2EnzymesIBA
06/2016 - 01/2014
2gadolinium ethoxybenzyl DTPAFDA Link
01/2016 - 01/2013
2GemcitabineFDA Link
05/2015 - 08/2013
2FollistatinIBA
08/2013 - 01/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2013 - 02/2005
2AlbuminsIBA
12/2012 - 02/2011
2Alanine Transaminase (SGPT)IBA
07/2011 - 11/2010
2Tumor Biomarkers (Tumor Markers)IBA
03/2007 - 02/2005
1GTP Phosphohydrolases (GTPases)IBA
04/2022
1laminin 10IBA
04/2022
1Technetium (Technetium 99m)IBA
02/2022
1MicroRNAs (MicroRNA)IBA
10/2021
1Protein Isoforms (Isoforms)IBA
06/2021
1IntegrinsIBA
06/2021
1DiureticsIBA
05/2021
1Natriuretic AgentsIBA
05/2021
1Aquaporin 2IBA
05/2021
1Transaminases (Aminotransferases)IBA
05/2021
1Circulating Tumor DNAIBA
04/2021
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
12/2020
1Spironolactone (Aldactone)FDA LinkGeneric
12/2020
1Furosemide (Lasix)FDA LinkGeneric
12/2020
1Fetal Proteins (Fetoprotein)IBA
07/2020
1JNK Mitogen-Activated Protein KinasesIBA
01/2020
1VaccinesIBA
02/2019
1Alkaline PhosphataseIBA
01/2019
1entecavirFDA Link
01/2019
1adefovir dipivoxil (Hepsera)FDA Link
01/2019
1DipeptidesIBA
10/2018
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2018

Therapy/Procedure

12Therapeutics
02/2018 - 07/2004
9Liver Transplantation
02/2022 - 12/2011
9Radiofrequency Ablation
08/2020 - 02/2009
5Drug Therapy (Chemotherapy)
07/2020 - 11/2007
2Pancreaticoduodenectomy
08/2013 - 03/2012